摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

叔丁基二苯基膦 | 6002-34-2

中文名称
叔丁基二苯基膦
中文别名
叔丁基二苯基磷
英文名称
tert-butyldiphenylphosphine
英文别名
diphenyl-tert-butylphosphane;diphenyl(tert-butyl)phosphine;(tert-butyl)diphenylphosphane;diphenyl-t-butylphosphine;tert-butyl(diphenyl)phosphane
叔丁基二苯基膦化学式
CAS
6002-34-2
化学式
C16H19P
mdl
——
分子量
242.301
InChiKey
QZUPHAGRBBOLTB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    52-55 °C(lit.)
  • 沸点:
    144-146 °C2 mm Hg(lit.)
  • 闪点:
    >230 °F
  • 稳定性/保质期:

    在常温常压下稳定,应避免与强氧化剂接触。

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

安全信息

  • TSCA:
    No
  • 安全说明:
    S26,S37
  • 危险类别码:
    R22,R36/37/38
  • WGK Germany:
    3
  • 危险品运输编号:
    NONH for all modes of transport
  • 海关编码:
    2902909090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P201,P261,P280,P305+P351+P338,P308+P313
  • 危险性描述:
    H315,H317,H319,H335,H360
  • 储存条件:
    密封保存

SDS

SDS:28c5b7606812b73ce20d1990a9a3ad36
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : tert-Butyldiphenylphosphine
CAS-No. : 6002-34-2
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
This substance is not classified as dangerous according to Directive 67/548/EEC.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C16H19P
Molecular Weight : 242,30 g/mol

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Oxides of phosphorus
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Normal measures for preventive fire protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Air sensitive. Handle and store under inert gas.
Specific end use(s)
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Impervious clothing., The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: liquid
Colour: light yellow
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 52 - 57 °C
point
f) Initial boiling point and 144 - 146 °C at 3 hPa - lit.
boiling range
g) Flash point > 110 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
Air
Incompatible materials
Strong oxidizing agentsStrong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

叔丁基二苯基主要用于作为研究用化合物。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    叔丁基二苯基膦15-冠醚-5sodium 作用下, 以 四氢呋喃 、 mineral oil 为溶剂, 反应 17.0h, 生成 四苯基二膦
    参考文献:
    名称:
    通过钠选择性裂解C-P键从ArCl制备有机膦的方法
    摘要:
    研究了磷化钠R 2 PNa和其他碱金属磷化物R 2 PM(M = Li和K)的制备,应用和反应机理。R 2 PNa可以通过SD(精细分散在矿物油中的钠)与次膦酸酯R 2 POR'和氯膦R 2 PC1的反应准确而选择性地制备。R 2 PNa也可以通过选择性裂解C–P键由三芳基膦和二芳基膦制备。在这些反应中,Na优于Li和K。R 2 PNa与多种ArCl反应以有效产生R 2PAr。ArCl优于ArBr和ArI,因为它们只会降低产品收率。另外,Ph 2 PNa优于Ph 2 PLi和Ph 2 PK,因为Ph 2 PLi不产生与PhCl的偶联产物,而Ph 2 PK仅产生低产率的产物。ArCl苯环上的吸电子基团极大地促进了与R 2 PNa的反应,而烷基降低了反应活性。氯乙烯和烷基氯RC1也有效地反应。当t-BuCl没有产生相应的产物,金刚烷基卤化物可以高产率得到相应的膦。通过这种方法,由相应的氯化物制备了多种膦。还可以方便地从Ph
    DOI:
    10.1021/acs.organomet.0c00295
  • 作为产物:
    描述:
    diphenyl(tert-butyl)phosphine oxiden 作用下, 以 四氢呋喃 为溶剂, 反应 20.0h, 以50%的产率得到叔丁基二苯基膦
    参考文献:
    名称:
    [Cp 2 ZrHCl] n在磷化学中有用的还原剂
    摘要:
    描述了用[Cp 2 ZrHCl] n选择性还原PO,PS,>CC<,CO键,以及卤化物交换的方法。
    DOI:
    10.1016/s0040-4039(97)01365-8
  • 作为试剂:
    描述:
    2,4-二氯-6-甲基嘧啶4-三氟甲基苯硼酸 在 palladium diacetate 、 N,N-二异丙基乙胺叔丁基二苯基膦 作用下, 以 异丙醇 为溶剂, 以74%的产率得到2-chloro-4-methyl-6-(4-(trifluoromethyl)phenyl)pyrimidine
    参考文献:
    名称:
    [EN] SYNTHESIS OF COMPOUNDS THAT MODULATE USE-DEPENDENT VOLTAGE-GATED SODIUM CHANNELS
    [FR] SYNTHÈSE DE COMPOSÉS QUI MODULENT DES CANAUX SODIQUES SENSIBLES À LA TENSION EN FONCTION DE L'UTILISATION
    摘要:
    本公开提供制备螺环衍生物的方法,特别是制备(2R,5S)-7-甲基-2-[4-甲基-6-[4-(三氟甲基)苯基]嘧啶-2-基]-1,7-二氮杂螺[4.4]壬烷-6-酮,以及用于上述方法的中间体。
    公开号:
    WO2022133097A1
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UN ANTAGONISTE DU RÉCEPTEUR DE L'OREXINE
    申请人:MERCK SHARP & DOHME
    公开号:WO2012058129A1
    公开(公告)日:2012-05-03
    The present invention is directed to processes for preparing a pyridyl piperidine compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.
    本发明涉及制备吡啶哌啶化合物的方法,该化合物是促进睡眠的受体拮抗剂,可用于治疗或预防涉及促进睡眠的神经和精神障碍和疾病。
  • Transient Protection of Organic Azides from Click Reactions with Alkynes by Phosphazide Formation
    作者:Tomohiro Meguro、Suguru Yoshida、Kazunobu Igawa、Katsuhiko Tomooka、Takamitsu Hosoya
    DOI:10.1021/acs.orglett.8b01692
    日期:2018.7.6
    A method for protecting organic azides from click reactions with alkynes is reported. Treatment of azides with Amphos affords phosphazides, which are stable under click reaction conditions and are easily converted back to azides by treatment with elemental sulfur. Thus, the method allows for facile modification of azide compounds via site-selective click reactions.
    报道了一种保护有机叠氮化物免于与炔烃发生点击反应的方法。用Amphos处理叠氮化物可得到叠氮化物,该叠氮化物在点击反应条件下稳定,并且通过用元素处理可轻易转化回叠氮化物。因此,该方法允许通过位点选择性点击反应容易地改性叠氮化物
  • Solid state frustrated Lewis pair chemistry
    作者:Long Wang、Gerald Kehr、Constantin G. Daniliuc、Melanie Brinkkötter、Thomas Wiegand、Anna-Lena Wübker、Hellmut Eckert、Lei Liu、Jan Gerit Brandenburg、Stefan Grimme、Gerhard Erker
    DOI:10.1039/c8sc01089g
    日期:——
    substitution. In the solid state deactivation is effectively suppressed and the active frustrated phosphane/borane Lewis pair splits dihydrogen or adds to sulfur dioxide. A variety of phosphane/B(C6F5)3 pairs have been used to carry out active FLP reactions in the solid state. The reactions were analyzed by DFT calculations and by solid state NMR spectroscopy. The solid state dihydrogen splitting reaction
    在溶液中,PCy 3 / B(C 6 F 5)3对通过亲核芳族取代迅速失活。在固态状态下,失活得到有效抑制,活性受阻的膦/硼烷路易斯对分解二氢或添加到二氧化硫中。各种膦/ B(C 6 F 5)3对已用于在固态下进行活性FLP反应。通过DFT计算和固态NMR光谱分析反应。固态二氢裂解反应也在接近室温的条件下进行,其中非猝灭的膦/硼烷混合物悬浮在含液体全氟甲基环己烷中。
  • A Lewis Base Nucleofugality Parameter, <i>N</i><sup><i>F</i></sup><sub>B</sub>, and Its Application in an Analysis of MIDA-Boronate Hydrolysis Kinetics
    作者:Nicholas P. Taylor、Jorge A. Gonzalez、Gary S. Nichol、Andrés García-Domínguez、Andrew G. Leach、Guy C. Lloyd-Jones
    DOI:10.1021/acs.joc.1c02729
    日期:2022.1.7
    The kinetics of quinuclidine displacement of BH3 from a wide range of Lewis base borane adducts have been measured. Parameterization of these rates has enabled the development of a nucleofugality scale (NFB), shown to quantify and predict the leaving group ability of a range of other Lewis bases. Additivity observed across a number of series R′3–nRnX (X = P, N; R′ = aryl, alkyl) has allowed the formulation
    已经测量了从广泛的路易斯碱硼烷加合物中置换 BH 3的奎宁环动力学。这些速率的参数化使得能够开发出离核量表 (NF B ),以量化和预测一系列其他路易斯碱基的离去基团能力。在多个系列 R' 3– n R n X (X = P, N; R' = 芳基, 烷基) 中观察到的可加性允许制定相关的取代基参数 ( n f PB , n f AB ),提供了一种方法计算N F B一系列路易斯碱基的值远远超出了实验得出的值。通过取代基参数n f PB与一系列烷基和芳基 MIDA 硼酸盐在中性条件下的解速率的相关性,探索了核离性参数的效用。这允许鉴定具有接近反应中心的杂原子的 MIDA 硼酸盐,显示出不寻常的动力学不稳定性或解稳定性。
  • Catalytic Preparation of Cyclic Carboxylic Esters
    申请人:Spindler Felix
    公开号:US20090275761A1
    公开(公告)日:2009-11-05
    Preparation of cyclic esters by hydrogenation of a carbonyl group in at least one anhydride radical —C(O)—O—C(O)— of a cyclic dicarboxylic or polycarboxylic anhydride by means of hydrogen in the presence of a homogeneous noble metal catalyst, characterized in that the hydrogenation is carried out in a homogeneous reaction mixture using an iridium catalyst. The cyclic esters are obtained in good chemical and optical yields when prochiral anhydrides are used together with chiral iridium catalysts.
    通过在至少一个环状二羧酸酐基团—C(O)—O—C(O)—中的羰基团上加氢来制备环酯,所述环状二羧酸酐为环状二羧酸酐或多羧酸酐,通过在均相贵金属催化剂存在下使用氢气,在均相反应混合物中使用催化剂进行氢化反应。当使用外消旋酸酐与手性催化剂一起时,可以获得良好的化学和光学产率。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫